Editorial: Targeting the interleukin-1β/interleukin-6/C-reactive protein pathway in clinical medicine - a road map to clinical trial design
Saved in:
| Main Authors: | Jan Torzewski, Ahmed Sheriff, Janos G. Filep, Karlheinz Peter, Paul M. Ridker |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1644576/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of combined cyclosporin and azithromycin treatment on human mononuclear cells under lipopolysaccharide challenge
by: Norah Alotaibi, et al.
Published: (2025-03-01) -
C-reactive protein conformations and their association with the IL-1β/IL-6 pathway in ocular inflammatory conditions
by: Mercedes S. Nabaes Jodar, et al.
Published: (2025-05-01) -
Interleukin-6-induced neuroinflammation is exacerbated by subclinical levels of interferon-α
by: Pattama Songkhunawej, et al.
Published: (2025-06-01) -
Immunohistochemical expression of IL-1β, IL-6, and NF-κβ in fibroids
by: Mateusz de Mezer, et al.
Published: (2025-07-01) -
Role of interleukins in heart failure with reduced ejection fraction
by: Oliwia Anna Segiet, et al.
Published: (2019-11-01)